Schedule 13G ownership disclosure

Syndax Pharmaceuticals Inc

Common Stock · CUSIP: 87164F105

Event date: 2025-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Wellington Management Group LLP

    Shares: 35,681.00 · Class: 0.0%

  • Wellington Group Holdings LLP

    Shares: 35,681.00 · Class: 0.0%

  • Wellington Investment Advisors Holdings LLP

    Shares: 35,681.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-25-000138
Form type
SCHEDULE 13G/A
Filer
Syndax Pharmaceuticals Inc
CIK
CIK 1395937
Filed
Mar 07, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub